Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ancora-SB

K-Number: K231323 · 2023-08-31

Decision Date2023-08-31
Product CodeFDA
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Ancora-SB is the device name listed in this FDA 510(k) record. The listed applicant is Aspero Medical, Inc.. It received FDA 510(k) clearance on 2023-08-31 under 510(k) number K231323. The device is classified under product code FDA. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ancora-SB?

Ancora-SB is a medical device that received FDA 510(k) clearance on 2023-08-31. The listed applicant is Aspero Medical, Inc.. The 510(k) number is K231323.

When did Ancora-SB receive FDA 510(k) clearance?

Ancora-SB received FDA 510(k) clearance on 2023-08-31, under 510(k) number K231323.

Who is the listed applicant for Ancora-SB?

The FDA 510(k) record lists Aspero Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Ancora-SB?

The FDA product code for Ancora-SB is FDA.

Other records listing Aspero Medical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: FDA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.